Literature DB >> 19213709

Genetic background and phenotypic characterization over two farrowings of leg conformation defects in Landrace and Large White sows.

X Fernàndez de Sevilla1, E Fàbrega, J Tibau, J Casellas.   

Abstract

A Bayesian threshold animal model was applied to evaluate the prevalence over 2 farrowings and genetic background of overall leg conformation score and the presence or absence of 6 specific leg defects (abnormal hoof growth, splay footed, plantigradism, straight pasterns, sickle-hocked legs, and the presence of swelling or injuries) in purebred Landrace and Large White sows. Data sets contained phenotypic records from 2,477 and 1,550 Landrace and Large White females, respectively, at the end of the growing period. Leg conformation data from first and second farrowings were available for 223 and 191 Landrace sows and 213 and 193 Large White sows, respectively. Overall leg conformation deteriorated with age, with statistically relevant differences between females at the end of the growing period, first farrowing (FF), and second farrowing (SF). In a similar way, the prevalence of the 6 specific leg defects increased between the end of the growing period and FF (with the exception of straight pasterns in the Landrace population). Differences between FF and second farrowing were statistically relevant for hoof growth (highest posterior density regions at 95% did not overlap), plantigradism, sickle-hocked legs, and overall leg conformation score in Landrace and for sickle-hocked leg and overall leg conformation score in Large White. The statistical relevance of the genetic background was tested through the Bayes factor (BF) between the model with the additive genetic component and the model with 0 heritability (nonheritable). Heritability (h(2)) was discarded (BF < 1) for sickle-hocked leg in both breeds, whereas decisive evidence (BF > 100) of genetic background was obtained for overall leg conformation score in Landrace and Large White sows (h(2) = 0.27 and 0.38, respectively), hoof growth in both breeds (h(2) = 0.22 and 0.26, respectively), and plantigradism (h(2) = 0.34) and the presence of swelling or injuries in Landrace (h(2) = 0.27). Note that a BF > 100 implies that the model with infinitesimal genetic effects was more than 100 times more suitable than the model without genetic effects, a conclusive estimate within the Bayesian framework. The remaining traits (splay footed and straight pasterns) registered BF values ranging from 11.6 to 35.1 and h(2) values ranging from 0.09 to 0.19. These results indicated a moderate genetic determinism for leg conformation in Landrace and Large White sows.

Entities:  

Mesh:

Year:  2009        PMID: 19213709     DOI: 10.2527/jas.2008-1200

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  3 in total

1.  Objective evaluation of female feet and leg joint conformation at time of selection and post first parity in swine1.

Authors:  Joseph D Stock; Julia A Calderón Díaz; Max F Rothschild; Benny E Mote; Kenneth J Stalder
Journal:  J Anim Sci       Date:  2018-09-07       Impact factor: 3.159

2.  Association and expression study of MMP3, TGFβ1 and COL10A1 as candidate genes for leg weakness-related traits in pigs.

Authors:  Watchara Laenoi; Noppawan Rangkasenee; Muhammad Jasim Uddin; Mehmet Ulas Cinar; Chirawath Phatsara; Dawit Tesfaye; Armin M Scholz; Ernst Tholen; Christian Looft; Manfred Mielenz; Helga Sauerwein; Klaus Wimmers; Karl Schellander
Journal:  Mol Biol Rep       Date:  2011-07-08       Impact factor: 2.316

3.  Quantitative trait loci analysis for leg weakness-related traits in a Duroc × Pietrain crossbred population.

Authors:  Watchara Laenoi; Muhammad Jasim Uddin; Mehmet Ulas Cinar; Christine Grosse-Brinkhaus; Dawit Tesfaye; Elisabeth Jonas; Armin M Scholz; Ernst Tholen; Christian Looft; Klaus Wimmers; Chirawath Phatsara; Heinz Juengst; Helga Sauerwein; Manfred Mielenz; Karl Schellander
Journal:  Genet Sel Evol       Date:  2011-03-20       Impact factor: 4.297

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.